Loading...
Bienvenue sur la collection HAL du laboratoire de BECCOH
Quelques conseils pour une publication "idéHALe"
• Pensez à respecter la signature institutionnelle
Université Paris-Saclay, UVSQ, BECCOH, 92104, Boulogne-Billancourt, France..
• Participez à l'accès ouvert
N'attendez pas : dès que votre article est en ligne, déposez dans Hal sa version acceptée pour publication et indiquez un embargo de 6 mois.
La loi pour une république numérique vous autorise en effet à partager cette version 6 mois après publications, quelque-soit l'éditeur
Plus d'informations Archives Ouverte : quid de mes droits d'auteurs ?
• Vous souhaitez disposer d'une page web référençant toutes vos publications ?
Créez vous en 5 minutes un idHal et un CVHAL
N'hésitez pas à nous contacter pour toutes questions,
nous serions ravis d'échanger avec vous hal.bib@uvsq.fr
nous serions ravis d'échanger avec vous hal.bib@uvsq.fr
Dernières Publications en accès ouvert dans Hal
-
Paul Takam Kamga, Marie Mayenga, Louise Sebane, Adrien Costantini, Catherine Julie, et al.. Colony stimulating factor-1 (CSF-1) signalling is predictive of response to immune checkpoint inhibitors in advanced non-small cell lung cancer. Lung Cancer, 2024, 188, pp.107447. ⟨10.1016/j.lungcan.2023.107447⟩. ⟨hal-04517531⟩
-
Julie Lecuelle, Caroline Truntzer, Debora Basile, Luigi Laghi, Luana Greco, et al.. Machine learning evaluation of immune infiltrate through digital tumour score allows prediction of survival outcome in a pooled analysis of three international stage III colon cancer cohorts. EBioMedicine, 2024, 105, pp.105207. ⟨10.1016/j.ebiom.2024.105207⟩. ⟨hal-04626841⟩
-
Robin Zagala, Nicolas Meyer, Philippe Saiag, Nora Kramkimel, Celeste Lebbe, et al.. Radiotherapy and prognostic factors in adnexal carcinomas: A retrospective study of 657 patients from the French CARADERM network. Journal of the European Academy of Dermatology and Venereology, In press, ⟨10.1111/jdv.20155⟩. ⟨hal-04626767⟩
-
Alexandra Kachaner, Raphaèle Seror, Fleur Cohen Aubart, Julien Henry, Thierry Lazure, et al.. Complete remission after a single bisphosphonate infusion in isolated bone Langerhans cell histiocytosis lesion: a case report and a narrative review of the literature. JBMR Plus, 2024, 8 (5), pp.ziae043. ⟨10.1093/jbmrpl/ziae043⟩. ⟨hal-04626829⟩
-
Johanne Seguin, Mostafa El Hajjam, Josette Legagneux, Sarah Diakhaby, Nathalie Mignet, et al.. Radiofrequency Combined with Intratumoral Immunotherapy: Preclinical Results and Safety in Metastatic Colorectal Carcinoma. Pharmaceutics, 2024, 16 (3), pp.315. ⟨10.3390/pharmaceutics16030315⟩. ⟨hal-04626840⟩
Mots clés
Anti-PD1
Anti-PD1 blockade
COVID-19
Radiofrequency ablation
Dabrafenib
Colon cancer
Sonic Hedgehog
Prognostic
BRAF
HIV
Metastatic cSCC
Targeted therapy
Biomarkers
Follow-up
Antineoplastic agents
ADAMTS13
Colorectal carcinoma
BRAFV600E mutation
Treatment
Osimertinib
AZD9291
Immunotherapy
Adjuvant FOLFOX
Staging
Safety
Plasma
Gastric bypass
Trametinib
Anti-PD-1
Liver metastases
Histiocytosis
Molecular targeted therapies
Survival
Anti-Tumor pharmacology
Circulating tumor DNA
Cancer bronchique non à petites cellules
Chemotherapy
Colorectal cancer
Immunohistochemistry
Locally advanced
Systemic therapy
Resistance
ALK
Non-small cell lung cancer
Immunothérapie
Advanced melanoma
Invasive cutaneous squamous cell carcinoma
Adjuvant therapy
Abscopal effect
Melanoma
Circulating cell-free DNA
Radiotherapy
Polyomavirus
Acute generalized exanthematous pustulosis
Adverse events
Crizotinib
BRAF V600-mutation
TNM classification
Immunomodulation
Toxicity
Mesenchymal stromal cells
AML
Anti-CTLA-4 anti-PD-1 elderly immune checkpoint inhibitors melanoma nonagenarian octogenarian
BRAF V600E
Cutaneous squamous cell carcinoma
Adjuvant
Antibody-drug conjugate
Nivolumab
Abdominal pain
Wnt
Assisted reproductive techniques
2-chlorodeoxyadenosine
Children
EGFR
Thrombosis
Prognosis
Prevention
ALK rearrangement
Surgical excision
Immune checkpoint inhibitor
Anti-CTLA-4
Anti-PD-1 antibody
ACTH
Oncology
ADN tumoral circulant
Abscopal effect anti-PD-1 antibody melanoma nivolumab pembrolizumab radiotherapy
Lung adenocarcinoma
Diagnosis
Lung cancer
Biomarker
Cemiplimab
Advanced
Adapted physical activity molecular diagnosis oligometastatic disease pancreatic adenocarcinoma KRAS mutation
Allelic imbalance
Merkel cell carcinoma
Chemoresistance
Cancer
Langerhans cell histiocytosis
Androgen insensitivity
Metastatic